12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersChromocell Therapeutics (AMEX:CHRO) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. Kineta (NASDAQ:KA) stock moved upwards
BenzingaApr 19 08:08 ET
Intelligent Bio Solutions Reports Preliminary Unaudited Fiscal Q3 Results
Seeking AlphaApr 18 14:58 ET
Express News | Intelligent Bio Solutions Sees Prelim. Q3 2024 Revenue $0.82M Vs $1.190M Est
Moomoo 24/7Apr 18 08:38 ET
Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS
Intelligent Bio Solutions Sees 3Q Rev of Around $820,000>INBS
Dow JonesApr 18 08:34 ET
Express News | Intelligent Bio - Cartridge and Reader Sales Are Expected to Increase 25% and 63%, Respectively, From July 1, 2023, Through to March 31, 2024
Moomoo 24/7Apr 18 08:31 ET
Express News | Intelligent Bio Solutions Inc - Sees Qtrly Year-Over-Year Increase of 17% in Cartridge Sales
Moomoo 24/7Apr 18 08:30 ET
Express News | Intelligent Bio Solutions Inc - Expects Approximate Unaudited Revenue of $0.82 Mln for Three Months Ended March 31, 2024
Moomoo 24/7Apr 18 08:30 ET
Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
Year-over-year unaudited revenue increased 80% for the fiscal third quarter and 193% for the nine months ended March 31, 2024, with highest quarterly cartridge sales since 2022 Intelligent Fingerprint
Intelligent Bio SolutionsApr 18 00:00 ET
Express News | Intelligent Bio Solutions Subsidiary Fingerprinting Granted New European Patent With Unitary Effect For DSR-Plus Cartridge Reader
Moomoo 24/7Apr 11 08:44 ET
Express News | Intelligent Bio Solutions: for Unit, Grant of European Patent With Unitary Effect for Dsr-Plus Cartridge Reader
Moomoo 24/7Apr 11 08:33 ET
Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio With Grant of New European Patent With Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge Reader
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing
Intelligent Bio SolutionsApr 11 00:00 ET
Looking Into Intelligent Bio Solutions's Recent Short Interest
Intelligent Bio Solutions's (NYSE:INBS) short percent of float has risen 57.64% since its last report. The company recently reported that it has 90 thousand shares sold short, which is 3.2% of all reg
BenzingaApr 5 12:45 ET
Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYC
NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing
Intelligent Bio SolutionsMar 26 00:00 ET
Express News | Intelligent Bio Solutions Inc Files For Offering Of Up To 6.8M Shares By The Selling Stockholders
Moomoo 24/7Mar 18 15:36 ET
Press Release: Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("IN
Dow JonesMar 12 19:30 ET
Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing
Intelligent Bio SolutionsMar 12 00:00 ET
Express News | Intelligent Bio Solutions Announces $10.1M Private Placement Priced At-The-Market Under Nasdaq Rules
Moomoo 24/7Mar 11 08:33 ET
Press Release: Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the
Dow JonesMar 11 08:30 ET
Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing
Intelligent Bio SolutionsMar 11 00:00 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersAinos (NASDAQ:AIMD) shares increased by 144.6% to $2.74 during Friday's pre-market session. The company's market cap stands at $12.8 million. Psyence Biomedical (NASDAQ:PBM) stock moved upwards
BenzingaMar 8 08:09 ET
No Data
No Data